Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies

This integrated analysis evaluated the efficacy and safety of once-daily tadalafil at doses of 2.5 mg and 5 mg over 12 weeks in 1,913 men with erectile dysfunction (ED) across various subpopulations, including different ages, ethnicities, comorbidities, and ED characteristics. Both tadalafil doses significantly improved erectile function compared to placebo,